TScan Therapeutics (TCRX) Non-Current Deffered Revenue (2020 - 2025)
TScan Therapeutics' Non-Current Deffered Revenue came in at $501,000 for Q1 2025, down 89.5% from $4.76 million a year earlier and down 59.8% from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Non-Current Deffered Revenue (2020 - 2025) Analysis & Trends
At the end of FY2024, TScan Therapeutics' Non-Current Deffered Revenue was $1.25 million, down 77.8% from FY2023.
- Non-Current Deffered Revenue carries a four-year compound annual growth rate of -38.7% (FY2020 to FY2024).
- Going back by year, Non-Current Deffered Revenue was $5.62 million in FY2023, $1.5 million in FY2021 (-83.0%) and $8.82 million in FY2020.
- The Q1 2025 figure represents the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2020.
- Year-over-year, Non-Current Deffered Revenue has declined for four consecutive quarters, with an average decline of 67.0% over the last four quarters.
- Business Quant data shows TCRX's Non-Current Deffered Revenue at $1.25 million (Q4 2024), $3.68 million (Q3 2024) and $3.96 million (Q2 2024) in the three quarters before Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | TScan Therapeutics | 41.58 Mn | 41.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 501,000.00 |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Mar 31, 2024 | 4.76 Mn |
| Dec 31, 2023 | 5.62 Mn |
| Sep 30, 2023 | 7.76 Mn |
| Jun 30, 2023 | 7.64 Mn |
| Dec 31, 2021 | 1.50 Mn |
| Sep 30, 2021 | 2.84 Mn |
| Jun 30, 2021 | 4.56 Mn |
| Dec 31, 2020 | 8.82 Mn |
API Access
TScan Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();